Lymphoproliferative disorders (LPDs) in immunosuppressed patients range from benign to malignant lymphoid proliferations, usually of B-cell derivation. 1,2 The World Health Organization (WHO) classification recognises 4 types of immunosuppressionassociated LPDs: (1) LPDs associated with primary immune disorders, (2) human immunodeficiency virus (HIV)-associated LPDs,(3) post-transplant lymphoproliferative disorders (PTLDs) and ( 4) other iatrogenic immunosuppression-associated LPDs. 3 Novel types of immunosuppression-associated LPDs that have emerged due to newer therapeutic agents and other less recognised immunosuppression settings have not been included in the current classification. 2 Viruses, in particular lymphotropic subtypes such as Epstein-Barr virus (EBV) and human herpesvirus-8 (HHV8), have long been associated with the pathogenesis of distinct LPDs, especially in immunosuppressed patients. 4,5 This review will discuss benign lymphoproliferative disorders in immunosuppressed patients, with an emphasis on entities commonly affecting the head and neck region. This study forms part of a special issue published by the Journal of Oral Pathology and Medicine covering the most important aspects of haematolymphoid lesions and neoplasms affecting the oral cavity and neighbouring structures.